Enimmune corporation (6564.TWO)
TWD 18.95
(-26.41%)
TWD 18.95
(-26.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -314.15 Million TWD | 13.81% |
| 2022 | -364.48 Million TWD | -230.44% |
| 2021 | -110.3 Million TWD | -20.2% |
| 2020 | -91.76 Million TWD | 25.01% |
| 2019 | -122.37 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -405.5 Million TWD | 0.0% |
| 2024 Q1 | - TWD | 100.0% |
| 2023 Q3 | -316 Million TWD | -5.87% |
| 2023 FY | -314.15 Million TWD | 13.81% |
| 2023 Q2 | -298.48 Million TWD | 0.61% |
| 2023 Q1 | -300.31 Million TWD | 17.6% |
| 2023 Q4 | -314.15 Million TWD | 0.58% |
| 2022 FY | -364.48 Million TWD | -230.44% |
| 2022 Q4 | -364.48 Million TWD | 0.51% |
| 2022 Q3 | -366.33 Million TWD | 0.0% |
| 2021 FY | -110.3 Million TWD | -20.2% |
| 2020 FY | -91.76 Million TWD | 25.01% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -307.766% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | -18.923% |
| Level Biotechnology Inc. | -453.9 Million TWD | 30.787% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -160.561% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | -59.961% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 162.851% |
| GlycoNex Incorporation | -148.56 Million TWD | -111.459% |
| VBI | -25.31 Million TWD | -1140.95% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 880.209% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 327.66% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -19.642% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 1127.402% |
| Visgeneer Inc. | 31.28 Million TWD | 1104.216% |
| Mycenax Biotech Inc. | 207 Million TWD | 251.761% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 53.841% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -134.007% |
| Neith Corporation | -150.31 Million TWD | -109.006% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 150.546% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -444.866% |
| TaiRx, Inc. | -147.86 Million TWD | -112.458% |
| CHO Pharma, Inc. | -203.79 Million TWD | -54.157% |
| EirGenix Inc. | -4.58 Billion TWD | 93.153% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -270.632% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 359.913% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 90.238% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 1.027% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -1485.621% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 1087.642% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 718.972% |
| RBC Bioscience Corporation | 422.18 Million TWD | 174.413% |
| BiOptic Inc. | 12.59 Million TWD | 2594.909% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 66.735% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -209.559% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -90.197% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 199.773% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -388.424% |
| NaviFUS Corp. | -123.12 Million TWD | -155.146% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 524.247% |
| Sinew Pharma Inc. | -160.34 Million TWD | -95.927% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -29.875% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 6.881% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 23.866% |
| AP Biosciences Inc | -196.52 Million TWD | -59.855% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 145.614% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -2646.865% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 62.135% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 123.145% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 24.277% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -50.073% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -118.374% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 4.956% |
| TCI GENE Inc. | -689.25 Million TWD | 54.42% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -164.137% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 76.004% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 1633.755% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -208.392% |
| PharmaEngine, Inc. | -860.8 Million TWD | 63.504% |
| Savior Lifetec Corporation | -812.54 Million TWD | 61.336% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | -4.731% |
| OBI Pharma, Inc. | -398.22 Million TWD | 21.11% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 14.028% |
| Acepodia, Inc. | -6.02 Billion TWD | 94.782% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 90.765% |